State University of New York - Downstate Medical Center
State University of New York - Downstate Medical Center
Explore linked clinical trials.9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-08-03 | NCT06030622 | |
| IMPRoving Outcomes in Vascular DisEase - Aortic Dissection | Type B Aortic Dissection | Recruiting | Not applicable | 2026-04-29 | NCT06087029 | |
| Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autism spectrum disorder, communication disorder, language disorder, nervous system disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-04-27 | NCT04060030 | |
| Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autism spectrum disorder, communication disorder, language disorder, nervous system disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder | Active, not recruiting | Phase 2 | 2026-04-27 | NCT04060017 | |
| Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autism spectrum disorder, communication disorder, language disorder, nervous system disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder | Active, not recruiting | Phase 2 | 2026-04-27 | NCT02839915 | |
| Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders | Neoplasms by Site, Nutritional and Metabolic Diseases, autism spectrum disorder, brain disorder, central nervous system cancer, central nervous system disorder, epilepsy, inborn mitochondrial metabolism disorder, metabolic disease, neoplasm, nervous system disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder | Recruiting | Not stated | 2026-04-23 | NCT04322734 | |
| Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 3 | 2026-01-22 | NCT01208662 | |
| The MIND-GUT Digital Pilot Intervention Study | Body Weight, Dysbiosis, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, anxiety, anxiety disorder, depressive disorder, nutritional disorder, obesity disorder, overnutrition, psychiatric disorder | Not yet recruiting | Not applicable | 2024-04-18 | NCT06374407 | |
| NICU Antibiotics and Outcomes (NANO) Follow-up Study | Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, pregnancy disorder | Not yet recruiting | Phase 3 | 2023-08-04 | NCT05977400 |